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A B S T R A C T   
Ionizing radiation interacts with the immune system in many ways with a multiplicity that mirrors the 
complexity of the immune system itself: namely the need to maintain a delicate balance between different 
compartments, cells and soluble factors that work collectively to protect, maintain, and restore tissue function in 
the face of severe challenges including radiation damage. The cytotoxic effects of high dose radiation are less 
relevant after low dose exposure, where subtle quantitative and functional effects predominate that may go 
unnoticed until late after exposure or after a second challenge reveals or exacerbates the effects. For example, 
low doses may permanently alter immune fitness and therefore accelerate immune senescence and pave the way 
for a wide spectrum of possible pathophysiological events, including early-onset of age-related degenerative 
disorders and cancer. By contrast, the so called low dose radiation therapy displays beneficial, anti-inflammatory 
and pain relieving properties in chronic inflammatory and degenerative diseases. In this review, epidemiological, 
clinical and experimental data regarding the effects of low-dose radiation on the homeostasis and functional 
integrity of immune cells will be discussed, as will be the role of immune-mediated mechanisms in the systemic 
manifestation of localized exposures such as inflammatory reactions. The central conclusion is that ionizing 
radiation fundamentally and durably reshapes the immune system. Further, the importance of discovery of 
immunological pathways for modifying radiation resilience amongst other research directions in this field is 
implied.   
1. Introduction 
The immune system is the body’s main defence mechanism able to 
distinguish between self and non-self as well as sensing danger. Its main 
function is to recognize and eliminate different pathogens and damaged 
or abnormal cells within the body (Fig. 1) (Murphy and Weaver, 2017). 
Direct ionizing radiation (IR) effects on the immune system are well- 
documented and were among the first radiobiological observations 
made soon after the discovery of X-rays (Anderson and Warner, 1976; 
Radiation, 1972; Schaue, 2017). With the discovery of antibiotics and 
anti-inflammatory drugs, together with an increased awareness of ra-
diation carcinogenesis the initial enthusiasm to treat infections and 
benign diseases with radiation subsided for the most part and was 
replaced with a sole focus on cancer radiotherapy (RT) using doses that 
can kill cancer cells (i.e. high doses delivered in multiple fractions, 
generally 2 Gy per daily fraction). As a result, the radiation literature 
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Fig. 1. Schematic representation of the structure of the immune system and its major functional features. A molecule that is recognized by the immune 
system is called an antigen, which can be both self and non-self in origin. The immune system can be divided in two main compartments: the innate immune system 
and the adaptive immune system. The innate immune system is composed of a cellular compartment consisting of mononuclear cells (monocytes/macrophages, mast 
cells), polymorphonuclear cells (neutrophils, basophils, eosinophils), dendritic cells (DCs), innate immune cells (e.g. natural killer or NK cells) and the humoral 
complement system (Artis and Spits, 2015). Innate immune cells see danger through their germline-encoded pattern recognition receptors (PRRs), which recognize 
specific molecular structures present on pathogens (so-called pathogen-associated molecular patterns or PAMPs) or produced by damaged cells (so-called damage- 
associated molecular patterns or DAMPs) (Amarante-Mendes et al., 2018). Forming our first-line of defense, this recognition is relatively non-specific and quick, 
reaching its maximal intensity shortly after antigen encounter without yielding specific immunological memory. Phagocytosis is one of the main mechanisms for 
antigen elimination by innate immune cells. During danger recognition and antigen processing innate immune cells mature and release various soluble immune 
mediators called cytokines and chemokines, which drive inflammation and attract adaptive immune cells (Commins et al., 2010). In fact, an important role of the 
innate immune system is the activation of the adaptive arm. Macrophages and DCs in particular are professional antigen presenting cells with the unique ability to 
activate naïve cells of the adaptive immune system by displaying components of the processed antigens within the major histocompatibility complex (MHC) on their 
surface and present them to lymphocytes in the presence of necessary co-stimulatory signals (Wynn et al., 2013). Cells of the adaptive immune system include T 
lymphocytes (such as CD4 + helper, CD8 + cytotoxic and Foxp3 + regulatory) and B lymphocytes. T cells are responsible for cell-mediated immune response while B 
cells play role in humoral immune response (mediated by antibodies). In contrast to the innate immune system, the major features of the adaptive immune response 
are: high antigen specificity, latency of maximal response and development of immunological memory exemplified by faster and qualitatively different recall re-
sponses (Santana and Esquivel-Guadarrama, 2006). The first step in the activation of the adaptive immune system is antigen recognition by CD4 + or CD8 + cells 
through their highly antigen-specific T-cell receptors (TCRs). Professional antigen presenting cells present antigenic peptides conjugated either to MHCII, inducing 
CD4 + activation or to MHCI, contributing to CD8 + activation. Activated CD8 + T cells kill the antigen-presenting cells through the release of cytotoxic agents stored 
in intracellular granules, or directly by cell-to-cell contact engaging death receptors, or through the production of cytokines that trigger apoptosis. B cells, on the 
other hand, recognize extracellular antigens via their antigen-specific B cell receptor, which are essentially antibodies bound on the cell membrane forming a 
transmembrane receptor. Once activated with help from CD4 + T cells, B cells start to divide and differentiate into plasma cells which secrete huge numbers of 
soluble antibodies similar to the one that recognized the antigen in the first place (Hardy and Hayakawa, 2001). Circulating antibodies bind to their specific antigens 
and these antigen–antibody complexes induce activation of the complement system, which in turn leads to a rapid neutralisation by the proteolytic activity of the 
complement system and further phagocytosis by innate cells, i.e. antibody-dependent cellular cytotoxicity. Most of the intercellular communication in the immune 
system is guided through a complex system of chemokines, cytokines and interferons that affect trafficking, activation, differentiation and functional maturation 
(Turner et al., 2014). To prevent tissue damage from excessive immune activation multiple control mechanisms are in place that act through cell-to-cell contact or 
cytokines, involving among others regulatory T cells (Tregs) (Persa et al., 2015). Finally, to mount an effective response, immune components must circulate between 
the blood and lymph nodes, recognize antigens upon contact with presenting cells, and differentiate to effector T cells and plasma cells. Moreover, these cells must 
extravasate the lymph nodes, migrate to affected tissue to secure host-protective activities and to recircle to blood to counteract chronic activation (Germain et al., 
2012). Accordingly, one has to consider a high degree of cellular motility and interaction dynamics of the immune system. 
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tends to be dominated for the most part by high dose exposure studies 
with single doses above 1 Gy (Schaue, 2017). Data from radiation 
oncology patients come with generally well-defined dosimetry and 
clinical monitoring, but the presence of a tumour is an important con-
founding factor from an immunological point of view. For instance, 
many patients receive fractionated local tumor irradiation of up to 74 Gy 
total dose as part of an extensive combined modality treatment that can 
include chemotherapy, surgery and/or immunotherapy (Demaria et al., 
2015). Therefore immunological alterations during cancer treatment 
may not necessarily be due to radiation effects alone. Studies based on 
high dose IR applied to cancer patients indicated that radiation had 
immune suppressive properties and this paradigm prevailed in the sci-
entific literature for decades (Anderson and Warner, 1976; Balogh et al., 
2013; Hader et al., 2020; Kachikwu et al., 2011; Lumniczky and Safrany, 
2015; McFarland et al., 2012; Merrick et al., 2005). On the other hand 
low (below 100 mGy) and intermediate dose (between 100 mGy and 1 
Gy) exposure scenarios are much more relevant for the general popu-
lation as they may have public health consequences. They are also much 
more difficult to study because toxicity and carcinogenesis are a lot less 
obvious while other, more subtle functional alterations gain in impor-
tance. DNA damage correlates with the dose and the probability of se-
vere direct DNA damage after low doses and dose rates is low, thus other 
mechanisms may prevail (Mothersill and Seymour, 2014). Within the 
long time span between exposure and the onset of the clinically apparent 
pathologies, likely persisting alterations in the functional integrity of the 
organism as a whole must be present leading to the development of a 
pathology. Not only the DNA-damage response (DDR) related pathways, 
but also other, immune-related pathways may contribute to both cancer 
and non-cancer health outcomes from exposure to IR. Hence, a holistic 
approach that integrates these multiple mechanisms at all organiza-
tional levels is needed to understand the complex response system 
(Mavragani et al., 2016). 
An accumulating amount of scientific evidence based on epidemio-
logical and pre-clinical studies indicate that low dose exposures might 
directly impact immune functions and - although controversial -, these 
data indicate that IR may not only be immune suppressive (Cui et al., 
2017; Hellweg, 2015; Makinodan and James, 1990; Rodel et al., 2015; 
Sambani et al., 1996; Xu et al., 1996). A comprehensive review of 
available data on IR effects on the immune system was published in the 
UNSCEAR 2006 report (Radiation, 2008) including both high and low 
dose effects and highlighted complex functional changes within the 
immune system in response to radiation. This was the first report 
released by an international organisation investigating radiation health 
effects which abandoned the “classical” paradigm that IR is purely im-
mune suppressive. Actually, this report proposes to consider IR as an 
immunomodulatory agent due to the multitude and sometimes opposing 
ways it can influence the immune system depending on various pa-
rameters such as dose, dose rate, genetic background, age, health status, 
comorbidities, lifestyle, environmental co-stressors, etc (Radiation, 
2008). 
This review is part of a collection of papers summarizing discussions 
of the MELODI workshop on non-cancer effects of low dose IR, organized 
in Sitges, Spain, 10–12 April 2019. Here we aim to provide an update on 
low dose IR effects on the human immune system with the goal to 
summarize what is “known”, what is suspected but still controversial 
and what is “not yet known” based on existing epidemiological, clinical 
and pre-clinical data (Table 1). 
2. Human biomonitoring and epidemiological data on low dose 
radiation-induced immunological changes 
Data from genuine epidemiological studies on immune alterations in 
the context of low dose exposures remain scarce (Table 2). This may be 
because symptoms of immune-related diseases do not appear in a form 
or along a time course that can easily be related to radiation exposure 
apart from the well-known high radiation sensitivity of many resting 
lymphocytes. 
A substantial amount of data is available from different mass casu-
alties implying acute or chronic exposure scenarios. Among the best 
studied cohorts today are A-bomb survivors and clean-up workers (liq-
uidators) of the Chernobyl nuclear power plant accident, subjected to 
single dose acute exposure. 
2.1. A-bomb survivors and Chernobyl clean-up workers cohorts 
Data regarding radiation effects on the immune system of A-bomb 
survivors started to accumulate in the 1980′s and have been periodically 
updated ever since. The caveat is of course that there may be influences 
of race and life style factors. Akiyama reported from the Life Span Study 
on about 120,000 people who had been exposed to an average of 0.16 Gy 
according to the dosimetry system revised in 1986 (DS86), which in-
cludes “non-exposed” controls (Akiyama, 1995; Akiyama et al., 1983). 
Many long-term immune effects were observed that generally suggested 
a shift in the peripheral lymphocyte balance in favor of B cells with 
increased serum immunoglobulin (Ig) levels at the expense of cluster of 
differentiation 3 (CD3) + T cells which were reduced in both numbers 
and functionality. A dose-dependent drop in naïve CD4+ and CD8+ T 
lymphocytes was recorded, while memory cells were less affected 
(Kusunoki et al., 1998; Kusunoki et al., 2003). That T cell differentiation 
and development may be permanently altered was suggested by a rise in 
rare double negative CD4-CD8-, alpha/beta T cells (Kusunoki et al., 
2003; Kyoizumi et al., 2010). The appearance and persistence of TCR- 
mutant T cells was detected mostly in the memory CD4+ T cell 
compartment in a dose-dependent manner in individuals aged 20 or 
older at the time of bombing (Kusunoki et al., 2003). A relatively robust 
dose-dependent readout for TCR mutant frequency was suggested after 
studies on Chernobyl clean-up workers, even at doses of 0.25 Gy (Saenko 
et al., 2000). This would suggest the use of TCR mutation as a potential 
biodosimeter relevant to T cell function. 
In many ways, immune changes observed in A-bomb survivors 
resemble those associated with aging. It was reported that the output of 
naïve T cells was reduced, the memory T cell pool was expanded while 
the TCR repertoire became limited, all of which were associated with 
low grade inflammation that involved myeloid cells known as inflam-
maging (Denkinger et al., 2015; Franceschi et al., 2019; Fulop et al., 
2018; Kusunoki and Hayashi, 2008; Kusunoki et al., 2010). Doses in the 
range of 0.005–0.2 Gy drove accelerated thymic involution, which could 
still be evident 30 years later when the natural, age-related process was 
well under way if not completed (Ito et al., 2017). The frequency and 
counts of monocytes were dose-dependently increased by radiation 
exposure and this increase was more pronounced after 60 years showing 
a possible acceleration of age-dependent clonal haematopoiesis (Yosh-
ida et al., 2019). However, the response to vaccination in elderly atomic 
bomb survivors seemed not to be impaired by radiation exposure early 
in life (Hayashi et al., 2018). 
The role of IR in promoting accelerated aging was further demon-
strated by looking at telomere length in leukocytes of A-bomb survivors. 
Lustig et al. showed that circulating leukocytes in A-bomb survivors had 
shorter than expected telomeres, and impaired function, which was 
dependent on dose and age at exposure. It was more severe in the young 
than in the elderly, showing a significant dose-dependency in 
Table 1 
Doses and dose ranges and main type of studies related to the relevant dose 
ranges aprincipal type of studies discussed in this review addressing this dose 
range. RT: radiotherapy; LD-RT: low-dose radiotherapy.   
Low doses Intermediate doses High doses 
Dose 
range 
<100 mGy 100 mGy–1 Gy >1 Gy 
Studiesa Epidemiological 
Experimental 
Epidemiological Clinical 
(LD-RT) Experimental 
Clinical (RT) 
Experimental  
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Table 2 
Overview of studies describing immunological changes in people exposed to different scenarios of irradiation.  
Citation Population/Site Collective & Numbers Dose Endpoints Remarks & Conclusions 
Acute and 
chronic 
exposure      
(Ito et al., 2017) A-bomb 
survivors 
Cohort, 165 human tissue 
blocks from RERF archive 
no (<5 mGy), low (5–200 
mGy), moderate-to-high 
(<200 mGy) exposure; 11 
unexposed controls 
Immunohistology of thymus from 
pathology archive 
Low dose is sufficient to result in 
decreased thymic function many 
years after exposure (years from 
exposure 9–41), accelerated 
thymus aging (involution) 
(Kusunoki et al., 
1998) 
A-bomb 
survivors 
Cohort, 159 exposed, 234 
controls (<0.05 Gy) 
1) <5 mGy; 2) >5 mGy to 
>1.5 Gy 
PBMCs by flow cytometry, subsets 
of T, B, NK cells 
A-bomb radiation might have 
triggered dominant Th2-cell 
responses, stimulating B-cell 
lymphopoiesis for a long period. 
(Kusunoki et al., 
2003) 
A-bomb 
survivors 
Cohort, 1280 individuals 2 groups: <5 mGy and >5 
mGy 
Subsets of CD4+ T cells Memory CD4+ T-cells of 
individuals who received 
significant radiation doses in 
adulthood may have become 
dependent on a much less TCR Vß 
families than unexposed 
(Kusunoki et al., 
2010) 
A-bomb 
survivors 
Cohort, 1035 individuals 
between 2006 and 2008 
dose categories: <5 mGy, 5 
mGy–0.5 Gy, 0.5 Gy–1.0 Gy, 
1.0 Gy–4.0 Gy 
PBMCs by flow cytometry, plasma 
TNF-alpha level (only a subgroup) 
A-bomb survivors may have 
induced T-cell immunosenescence 
resulting in attenuation of T-cell- 
mediated immunity. 
(Kyoizumi et al., 
1992) 
A-bomb 
survivors 
203 A-bomb survivors, 6 
Thorotrast patients, 18 
thyroid disease patients; one 
Chernobyl person with high 
accidental exposure 
A-bomb survivors: 1) <5 mGy 
(n = 125); 2) >1.5 Gy (n=78) 
Mutation frequency of T-cell 
receptor (TCR) in PBMCs: flow 
cytometry with CD3 and CD4 
antibodies assuming that mutant 
CD4+ T cells have only a small 
fraction of CD3 expression 
No significant dose effects in A- 
bomb survivors. 
(Kyoizumi et al., 
2010) 
A-bomb 
survivors 
Cohort, 916 individuals dose categories: <5 mGy, 5 
mGy–0.5 Gy, 0.5 Gy–1.0 Gy, 
1.0 Gy–4.0 Gy 
PBMCs characterized by flow 
cytometry: subsets of memory T- 
cells by CD43 level 
The steady state of the T-cell 
memory, which is regulated by 
cell activation and/or cell survival 
processes in subsets may have 
been perturbed by prior radiation 
exposure. 
(Lustig et al., 
2016) 
A-bomb 
survivors 
Cohort, 415 individuals, 2 
time points: 55 and 66 years 
after exposure 
3 exposure groups: 157 with 
no dose (<5 mGy), 123 with 
low (5 mGy–700 mGy), 135 
with high (>700 mGy) dose 
T cell counts, telomere length; 
serum cytokines, c-reactive protein 
(CRP) 
Radiation damage drives changes 
in telomere length that persist in 
the progeny over half a century 
and therefore likely derived from 
the initial lesion. Radiation 
damage seems more severe in the 
young than the old. Telomere 
shortening likely cause functional 
defects that in the case of 
lymphocytes would lead to less T 
cell immunity and less myeloid 
function (less inflammatory 
cytokines). 
(Yoshida et al., 
2016) 
A-bomb 
survivors 
Cohort, 620 participants dose range 0–1.736 Gy PBMCs: telomere length of naïve 
and memory CD4+ T cells, total 
CD8+ T cells; metabolic status 
Radiation exposure perturbs T- 
cell homeostasis involving 
telomere length maintenance by 
multiple biological mechanisms, 
depending on dose, and that long- 
term radiation-induced effects on 
the maintenance of T-cell 
telomeres may be modified by the 
subsequent metabolic conditions 
of individuals. 
(Yoshida et al., 
2019) 
A-bomb 
survivors 
Cohort, 14,349 participants 3 dose groups; <1 Gy (n =
1616), >1 Gy (n = 9393), 
control (not-in-town, n =
3340) 
Longitudinal statistical analysis of 
blood cell counts 
Radiation exposure might 
accelerate aging-associated clonal 
haematopoiesis, which could 
result in a long-lasting elevation 
of circulating monocytes. 
(Ilienko et al., 
2018) 
Chernobyl 235 Chernobyl accident male 
clean-up workers exposed in 
1986–1987; 45 matched non- 
exposed controls 
Mean dose ± SD: 419.48 mSv 
± 654.60; range 0.10–3,500 
mSv 
Lymphoctes: gene expression of 
candidate genes: BCL2, CDKN2A, 
CLSTN2, GSTM1, IFNG, IL1B, 
MCF2L, SERPINB9, STAT3, TERF1, 
TERF2,TERT, TNF, TP53, CCND1; 
relative telomere length; immune 
cell subsets, γ-H2AX and CyclinD1. 
Cellular immunity, gene 
expression, telomere length, 
intracellular protein parameters 
are shown to be among 
perspective biological markers at 
a late period after radiation 
exposure. 
(Kuzmenok 
et al., 2003) 
Chernobyl Chernobyl healthy clean up 
workers from Belarus: 134 
workers and 89 matched 
controls 
Dose estimation: 150 
mGy–500mGy 
PBMCs; isolated T-cells; mitogen 
stimulation 
An approach to a more accurate 
analysis of the immunological 
disorders found after exposure to 
radiation from Chernobyl-related 
activities. 
(continued on next page) 
K. Lumniczky et al.                                                                                                                                                                                                                             
Environment International xxx (xxxx) xxx
5
Table 2 (continued ) 
Citation Population/Site Collective & Numbers Dose Endpoints Remarks & Conclusions 
(Oradovskaia 
et al., 2011a) 
Chernobyl Liquidators, comparison of 
different time points (1986, 
1987) and working 
conditions 
Differences by time and 
timing of liquidation work 
PBMC subpopulations; 
immunoglobulins 
Specific features of changes in the 
immune system depend on dose of 
external gamma-irradiation. 
However, distinctions in the age 
dynamics of the immune system 
in liquidators in the presence and 
in the absence of cancer 
manifested themselves in a stable 
level of CD3+, CD4+, CD8(+)-T- 
lymphocytes, immune regulation 
index, CD95+, serum IgA at the 
age between 40 and 70 years. 
(Saenko et al., 
2000) 
Chernobyl 57 liquidators, 21 controls Physical dosimetry from 
official records; Chernobyl 
liquidators <0.25 Gy 
erythrocyte variant cells bearing a 
mutated glycophorin A (GPA) 
surface marker 
In Chernobyl clean-up workers 
the TCR mutant frequency was 
significantly higher than in 
control non-irradiated 
individuals. 
(Chang et al., 
1999a) 
Home 
environment, 
Taiwan 
196 exposed residents with 
2–13 years of exposure in 
their homes; 55 close 
relatives non-exposed 
Protracted gamma-radiation, 
mean excess cumulative dose: 
169 +/− 272 mSv; mean 
annual excess dose 24+/−
29.9 mSv 
blood: lymphocyte subpopulations Significant immunological effects 
were observed in those who 
received chronic low-dose 
radiation exposure. 
(Jain and Das, 
2017) 
Kerala, India Cohort, 36 healthy male 
individuals, age 28–52 living 
in different level natural 
background radiation areas 
5 dose groups based on 
annual background dose 
received; I (control): <1.5 
mGy/year; II: 1.51–5.0 mGy/ 
year; III: 5.01–15.0 mGy/ 
year; IV: >15 mGy/year; 
individual dosimetry 
Gene expression in PBMCs, gene 
ontology, pathway analysis 
Individuals exposed to 
background doses of >5 mGy/ 
year showed alterations in the 
expression of genes involved in 
immune system-related pathways. 
(Takahashi 
et al., 1999) 
Marshall 
Islands 
Cohort, 4766 individuals 
aged to be at risk from 
exposure of radioactive 
fallout by the US nuclear 
testing programme on Bikini 
and Eniertah atoll (1946 and 
1958) 
No dose estimation provided Thyroid examination by 
ultrasound, thyroid hormone 
determination, anti-thyroid 
antibodies, questionnaire, iodine 
status (urine samples) 
Dietary intake of iodine needs to 
be taken into account when 
looking at the link between 
radiation exposure and thyroid 
nodules. 
(Attar et al., 
2007) 
Ramsar, Iran 100 individuals from villages 
with high level natural 
background radiation 
(HLNBR) and villages with 
low background radiation 
13 times higher than normal 
in HLNBR area 
PBMCs for functional assays, 
cytokines IL-2, IL-4, IL-10, IFN- 
gamma 
Immune system adaptation in 
individuals living in high natural 
radiation background areas 
(Borzoueisileh 
et al., 2013) 
Ramsar, Iran 50 individuals aged 25–35 
years, exposure duration 
10–35 years, different level 
natural background radiation 
areas 
estimated dose of 10.2–260 
mSv/year in Ramsar area 
Flow cytometry of PBMC 
subpopulations: CD4+/CD45+ (T- 
helper-cells), CD8+ (cytotoxic T- 
cells), NK cells and CD107a-cells 
Multiple immune system 
alterations 
(Ghiassi-nejad 
et al., 2002) 
Ramsar, Iran Individuals from HLNBR 
areas vs normal background 
radiation area 
Annual radiation absorbed 
dose from background 
radiation up to 260 mSv/year 
chromosome aberrations after in 
vitro challenge dose with 1.5 Gy 
An adative response in terms of 
chromosomal aberrations induced 
by chronic low dose exposure 
(Ghiassi-Nejad 
et al., 2004) 
Ramsar, Iran 50 exposed individuals from 
HLNBR area aged 40+/− 16 
years; 30 matched controls 
Estimated annual effective 
dose: 1.6–42 mSv/year; 2.3 
mSv/year for controls 
Immunoglobulins IgM, IgG, IgA, 
IgE, complement (C3, C4, C1- 
inactivator), rheumatoid factor, 
CRP; flow cytometry of PHA 
stimulated and unstimulated 
PBMCs with CD3, CD4, CD5, CD69 
markers; cytogenetic analysis 
Stimulation of Th2 response is 
discussed 
(Molaie et al., 
2012) 
Ramsar, Iran Subjects from high and low 
level natural background 
radiation areas 
high and low natural 
background radiation 
Neutrophil chemotaxis, Nitro-Blue 
Tetrazolium (NBT), antioxidant 
effects, cytokines (IL-2, IL-4) levels 
The level of IL-4 increased in 
individuals who lived in area with 
high levels of natural radiation, 
which could lead to Th2 pattern of 
immune response 
(Akleyev et al., 
2019) 
Techa River, 
Mayak area 
Cohort, 66 residents of the 
Techa River basin 
contaminated due to release 
of liquid radioactive waste 
from the Mayak Production 
Association (Plutonium) in 
1952; groups: 29 people with 
vs 37 people without 
increased TCR-mutations 
Dose estimation according to 
the Techa River Dosimetry 
system 2009 (TRDS-2009): 
main group (TCR-mutations): 
dose rate to bone marrow 
0.21+/− 0.02 Gy/year 1951, 
absorbed dose = 0.89+/ 
− 0.09 Gy (individual 
0.09–1.96 Gy) comparison 
group: dose rate to BM 0.25 
+/− 0.02 Gy/year 1951; 
absorbed dose = 1.03 +/−
0.07 Gy (range 0.03–2.34 Gy) 
Number of CD19+, CD3+, 
CD3+CD4+, CD3+CD8+, 
CD3+CD4+/CD3+CD8+ cell ratio, 
immunglobulins (IgA, IgM, IgG); 
number of neutrophils, monocytes 
and their phagocytotic, lysosomal 
activity and intensity of 
intracellular oxygen-dependent 
metabolism; eosinophils, 
basophils, CD16+CD56+ and 
CD3+CD16+CD56+ lymphocytes; 
cytokines; colony stimulating 
factors: GM-CSF, G-CSF, TNF- 
alpha; IFN-alpha, IFN-gamma 
Low dose exposure induced long 
term changes of the innate 
immune system; immune system 
seems to react to DNA damage 
driving innate immune cell 
activation in an effort to eliminate 
TCR-mutated lymphocytes other 
than by apoptosis 
(Li et al., 2019) lymphocyte subsets; 30 cytokines 
(continued on next page) 
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Table 2 (continued ) 
Citation Population/Site Collective & Numbers Dose Endpoints Remarks & Conclusions 
Yangjiang 
district, China 
100 women exposed to 
HLNBR, 100 matched 
controls 
estimated cumulative dose in 
exposed group: 58.5–249.13 
mSv 
Immune function was found to be 
affected in humans exposed to 
long-term low dose radiation: 
increase in CD8+ T-cell numbers 
and upregulated inflammatory 
biomarkers like IFN-gamma, 
MCP-1, sIL6R, EGFR, CRP 
(Gyuleva et al., 
2015a) 
Nuclear power 
plant workers 
Nuclear Power Plant (NPP) 
“Kozloduy”, Bulgaria. 438 
persons working in NPP; 10 
year survey 
Cumulative doses between 
0.06 mSv and 766.36 mSv 
and a control group with 65 
persons 
Flow cytometry of lymphocyte 
subpopulations, serum levels of 
IgG, IgA, IgM 
Assumption that while the 
adaptation processes are 
dominated with low prevalence of 
T-helper 1 (Th1) immune 
response to cumulative doses 
<100 mSv, a switch to TH-2 
response occured at doses >100 
mSv. 
(Gyuleva et al., 
2015b) 
Nuclear power 
plant workers 
NPP “Kozloduy”, Bulgaria. 
438 persons working in NPP; 
10 year survey 
Cumulative doses between 
0.06 mSv and 766.36 mSv 
and a control group with 65 
persons; 
Flow cytometry measurements of 
T, B, natural killer (NK) and natural 
killer T (NKT) cells 
Some of the studied parameters 
could be interpreted in terms of 
adaptation processes at low doses. 
At doses above 100–200 mSv, 
compensatory mechanisms might 
be involved to balance deviations 
in lymphocyte subsets. Some 
observed variations in some cases 
on the immune system might be 
due to other unknown factors. 
(Gyuleva et al., 
2018) 
Nuclear power 
plant workers 
NPP “Kozloduy”, Bulgaria. 
105 employees 
control, 4 dose groups: <25 
mSv; <100 mSv; <200 mSv; 
> 200 mSv 
lymphocyte subpopulations; serum 
IgG, IgM, IgA; IL-2, IL-4, IFN- 
gamma 
The observed even slight trends in 
some lymphocyte populations and 
in cytokines profile allow to 
assume a possibility of a gradual 
polarization of Th1 to Th2 
immune response at dose range 
100 to 200 mSv. 
(Rees et al., 
2004) 
NPP workers British Nuclear Fuels, 
Sellafield: 194 male radiation 
workers >200 mSv (mean 
331.5 mSv); 131 workers 
<27.5 mSv (mean 13.9 mSv) 
Film badge dosimetry over 
30.6 years vs 23.9 years; 
cumulative exposure >200 
mSv vs <27.5 mSv 
PBMCs: T cell and B cell subsets No significant immunological 
effects in male radiation workers 
at >200 mSv compared to <27.5 
mSv; smoking is an important 
confounding variable. 
(Ahmad et al., 
2016) 
Radiology 
workers 
60 healthy individuals 
working in different medical 
diagnostic units: 20 exposed, 
40 matched controls 
mean dose: 2.03 mSv/year; 
duration of radiation 
exposure: 16 years 
Superoxide, DNA oxidation, 
cytokines 
The data suggest a pro- 
inflammatory response at doses 
above 17 mSv. A threshold and 
non-linearity is discussed. 
(Godekmerdan 
et al., 2004) 
Radiology 
workers 
50 radiology workers vs 35 
age-matched healthy 
controls, mean age 30.1 +/−
7 vs 31.5 +/− 5.8 years; 48% 
vs 0% smokers; 
<3.5 mSv/year for 86%; the 
rest received above that; 
exposure time >5 years in 
48% 
Subgroups of PBMCs; serum 
complement and Igs 
T helper cell and humoral 
immune components are 
compromised. 
(Karimi et al., 
2017) 
Radiology 
workers 
30 radiology workers vs 20 
control laboratory workers 
Exposure <50 mSv PBMCs, PHA stimulation assay; 
serum cytokines 
No dose response tested. A shift 
towards Th1 responses by low 
dose radiation is discussed. 
(Klucinski et al., 
2014) 
Radiology 
workers 
X-ray diagnostics units: 47 
workers (14 men, 33 
women); control group 38 
(10 men, 28 women) non- 
exposed 
Period of employment: 1–33 
years with annual effective 
dose <1 mSv 
Flow cytometry of B-cell subsets: B- 
cells (CD19 + ), B1-cells (CD5+
CD19+ ), memory B-cells (CD27+
CD19+ ) 
Association of suppressive 
influence of low level ionizing 
radiation on B and memory B-cells 
is discussed. 
(Rybkina et al., 
2014) 
Mayak 
production 
workers 
Mayak Production 
Association workers cohort; 
91 workers and 43 controls 
14 workers exposed to 
external gamma-rays (total 
dose 05–3.0 Gy), 77 workers 
with combined exposure 
(external gamma-rays and 
internal alpha radiation from 
incorporated plutonium) 
Cytokines: TGF-beta1, TNF-alpha, 
IFN-gamma, IL-1beta, IL-8; 
immunoglobulins: IgM, IgG, IgA, 
IgE; p53, HSP70, MMP-9; 
lymphocyte subsets 
Chronic occupational IR exposure 
of workers induced a depletion of 
immune cells in peripheral blood 
(Zakeri et al., 
2010) 
Interventional 
cardiologists 
37 interventional 
cardiologist vs 37 control; 
8.14 mSv/year (range 
1.2–27.8) for 12.1 +/− 6.6 
years and an accumulated 
dose over the last 5 years of 
30.5 +/− 24.3 mSv 
serum cytokines and Igs; cytokine 
release from activated 
lymphocytes, PBMC phenotypes 
No dose response observed due to 
low case numbers 
Studies on 
radiation- 
exposed 
children      
(Imaizumi et al., 
2008) 
A-bomb 
survivors 
A-bomb survivors exposed in 
utero; 328 persons (mean age 
55.2 year; 162 male); 
examination 55–58 year after 
exposure in utero 
mean maternal uterine 
radiation dose 0.256 Gy; <5 
mGy, 5 mGy-0.1 Gy, 0.1–0.5 
Gy, 0.5–1 Gy, > 1 Gy 
Thyroid: solid thyroid nodules and 
cysts; blood: antithyroid antibodies 
(ATAs): antithyroperoxidase (TPO- 
Ab) and antithyroglobuline (TgAb) 
Antithyroid antibodies were not 
associated with dose or 
gestational week at exposure. No 
significant dose–response 
relationship for autoimmune 
thyroid disease in the in utero- 
(continued on next page) 
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individuals younger than 12-years at exposure. The authors concluded 
that because this was measurable in the progeny decades later, the initial 
lesion was the likely source. The association of telomere shortening with 
circulating biomarkers for aging, such as cytokine production and 
peripheral blood cell counts were lost in irradiated individuals indi-
cating that radiation effects override those of aging. The authors hy-
pothesized that the resultant functional defects may not necessarily be a 
disadvantage as myeloid cells may produce fewer inflammatory 
Table 2 (continued ) 
Citation Population/Site Collective & Numbers Dose Endpoints Remarks & Conclusions 
exposed subjects (similar to 
exposed children). 
(Chang et al., 
1999) 
Home 
environment, 
Taiwan 
289 children exposed at 
kindergarden in 1983–92 to 
continuous low dose Co-60 
gamma irradiation vs 751 
aged- and sex-matched 
exposed to lower dose, 
studied 5–7 years later 
High dose group estimated 
21–85 mSv in total (200-800 
chest X-rays) compared to 
low dose group 2–5 mSv 
(20–50 chest X-rays) 
Blood draw for basic differential 
blood counts 
Persistent changes in 
haematopoietic system following 
chronic low dose expsoures in the 
observed children. 
(Agate et al., 
2008) 
Chernobyl Cohort, 1433 sera from 
adolescents 13-17 years 
(born 1982–1986); 
additional 1441 control sera 
from aged-matched and sex- 
matched children in 
Denmark and Sardinia 
Contaminated areas included 
Klintsy (Russia), Korosten 
(Ukraine) and Lelchitsky 
(Belarus) at 555–1480 kBq/ 
m2; iodine deficiency 
prevalent in both 
contaminated and non- 
contamined areas; 
ATAs: TPO-Ab, TgAb; thyroid 
function based on circulating levels 
of thyroid-stimulating hormone 
(TSH) and free triiodothyronine 
(FT3) and thyroxine (FT4) 
TPO-AB prevalence in adolescents 
exposed to radioactive fallout was 
still increased in Belarus 13–15 
years but a lot less than at 6–8 
years after the Chernobyl accident 
but normal thyorid function 
possibly suggests a transient 
radiation-induced autoimmune 
reaction without triggering 
clinical thyorid autoimmune 
disease. 
(Chernyshov 
et al., 1997) 
Chernobyl 120 children aged 6–13 years 
from 15 radiation- 
contaminated areas in North 
Ukraine after Chernobyl 
accident with/withour 
recurrent respiratory disease 
(RRDC); 87 children from 
non-contaminated areas 
with/without RRDC 
Exposed children from areas 
within a 40–75 km radius 
from the reactor; estimated 
dose of Cs-137 and Sr-90 of 
0.57–3.09 mSv over 3 years; 
two groups < or >1 mSv 
Major lymphocyte subsets analysed 
in whole blood by flow cytometry 
Long-time exposure to low 
radiation doses may affect the 
immune balance, especially in 
vulnerable populations. 
(Kasatkina et al., 
1997) 
Chernobyl 89 children from Uritzky 
region (416 km north of 
Chernobyl); 116 non- 
contaminated Kolpnyansky 
area; 2 age groups: age at 
exposure in utero (n = 89 and 
n = 100 controls) or 8–9 
years (n = 81 and n = 97 
controls) 
Average Cs-137 soil 
contamination 1.71 Ci/km2 
(range 0.18–3.97) 
Thyroid dimension by clinical 
exam and ultrasound; thyroid 
function (hormones); 
autoantibodies; fine needle 
aspiration 
Autoimmune thyroid disease 
markedly increased in children 
with poor iodine nutrition who 
were exposed to low level 
radiation. Low level radiation 
may induce thyroid gland changes 
in children who had inadequate 
iodine intake. 
(Pacini et al., 
1998) 
Chernobyl 472 patients with thyroid 
carcinoma from Belarus 
diagnosed at <21 year 
compared to aged-matched 
controls with thyroid 
carcinoma from Italy and 
France: a) <14 year children 
(n = 372); b) adolescent 
14–21 year (n = 100); 
Radioactive contamination I- 
131 in Belarus: ranging from 
185 to 37,000 kBq/m2 
Thyroid immunity and function: 
T4, T3, TSH, thyroid ATAs: TPO- 
Ab, TgAb 
Young children (<5 year) are 
especially vulnerable to radiation- 
induced thyroid cancer that tend 
to be more aggressive in nature 
and associated with signs of 
thyroid autoimmunity 
(Sheikh 
Sajjadieh 
et al., 2012) 
Chernobyl Chernobyl area: children 
aged 4–18 years with/ 
without diagnosed irritable 
bowel disease 
Internal whole body 
radioactivity due to Cs-137; 
group1 (21 children aged 
4–9): 1.9 Bq, group2 (26 
children aged 10–13): 1.85 
Bq, group3 (28 children aged 
14–18): 2.01 Bq, group4 (21 
healthy childen aged 5–15): 
1.8 Bq 
Lymphocyte subsets, cytokines: IL- 
4, IFN-gamma 
Children with irritable bowel 
disease had less CD4+ T-cells, a 
higher level of IL-4 and a lower 
level of IFN gamma, suggesting a 
stronger polarization toward a 
Th2 phenotype. There was no 
difference with age, suggesting 
that there was no radiation-dose 
effect. 
(Vykhovanets 
et al., 2000) 
Chernobyl 6–14 year old children in 
radiation-contaminated 
areas in North Ukraine after 
Chernobyl accident (n = 78; 
5 years after accident) and 
141 different children (8–10 
years after accident); 
children with recurrent 
respiratory disease (RRDC, 
mean age 8.3 years) vs non- 
RRDC in contaminated areas; 
n = 61 (1991) and n = 87 
aged-matched controls from 
non-contaminated areas 
Low doses of radiation to the 
whole body from Cs-137 
ranging from 1.79 to 53.7 
mSv (1991) and 2.17–29.33 
mSv (1994–96) and various 
doses of radiation to the 
thyroid from I-131 as fallout 
Major lymphocyte subsets analysed 
in whole blood by flow cytometry 
Possibility that long-term 
exposure to low doses of Cs-137 
may have altered the immune 
balance in especially vulnerable 
children. The shifts in circulating 
lymphocyte subsets between 
healthy children and those with 
RRDC may be attributed to long- 
term low-dose exposure of the 
whole body to radiation from Cs- 
137 and exposure of the thyroid to 
radiation from I-131.  
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cytokines, whereas this argument is difficult to make for reduced T cell 
function (Lustig et al., 2016). Of special interest to the discussion here 
might be the observation by Yoshida el al. who showed a biphasic 
alteration of CD4+ telomere length with irradiation dose: longer telo-
meres after low dose exposure and progressively decreasing telomere 
length with doses above 0.5 Gy which correlated with the individual 
metabolic status (Yoshida et al., 2016). 
Further low-dose IR induced quantitative and functional alterations 
in immune parameters in Chernobyl clean-up workers were reported by 
Ilienko et al., who investigated cellular immune parameters of 235 in-
dividuals exposed to doses between 0.1 and 3500 mSv. They found 
decreased CD4+/CD8+ ratios and increased Tregs in 56% of the studied 
clean-up workers, especially in those exposed to low doses. Interest-
ingly, the authors showed that the decrease in the level of B cells and 
activated T cells correlated with the increase in interleukin (IL)-1β levels 
in individuals exposed to doses below 100 mSv (Ilienko et al., 2018). 
Oradovskaia et al. studied a cohort of clean-up workers who developed 
different malignant diseases and identified typical immune parameter 
changes in these people 1–3 years before the manifestation of cancer. 
These changes include reduced CD3+ CD4+ T cell levels, increased 
CD8+ T cell levels and hence a reduced CD4/CD8 ratio, and a preva-
lence for natural killer T (NKT) cells over conventional natural killer 
(NK) cells (Oradovskaia et al., 2011b) confirming previous data of 
increased NKT cells in clean-up workers (Kuzmenok et al., 2003). 
Though these markers seem to indicate a risk for cancer development, it 
is not clear to what extent these alterations were specific for radiation 
exposed individuals rather than the general population developing 
cancer at later times. 
2.2. Environmental or occupational radiation exposures 
Other exposure scenarios of interest are long-term chronic exposures 
affecting either residents living in regions with increased background 
radiation (natural or human-made) or workers occupationally exposed 
to radiation. Studies investigating individuals living in Ramsar, Iran at 
natural high background radioactivity of up to 260 mSv per year showed 
mild immunological alterations manifested in increased Ig levels (in 
particular IgE), increased levels of activated CD4+ cells and a tendency 
towards T helper 2 (Th2) polarization without changes in innate im-
mune parameters (in terms of neutrophil chemotaxis), while results 
relating to cytogenetic damage in blood lymphocytes were contradictory 
(Attar et al., 2007; Borzoueisileh et al., 2013; Ghiassi-nejad et al., 2002; 
Ghiassi-Nejad et al., 2004; Molaie et al., 2012). Studies investigating 
residents living in the Yangjian high background radiation area (with 
cumulative doses up to 249 mSv) showed an increased tendency of both 
CD4+ and CD8+ T cells in the peripheral blood mononuclear cells 
(PBMCs), the latter correlating with dose. Moreover, multiple 
inflammation-related cytokines and blood proteins were significantly 
increased, such as soluble IL-6 receptor (sIL-6R), interferon (IFN)-γ, 
monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein 
(CRP) (Li et al., 2019). Chang et al investigated home environments 
giving off on average 169 mSv gamma radiation from building materials 
to 196 individuals over 2–13 years. They found a change in lymphocyte 
subsets in favour of CD8+ T cells while CD4+ T cell numbers and CD4/ 
CD8 ratio negatively correlated with dose when compared to 55 non- 
exposed close relatives (Chang et al., 1999a). Despite the fact that the 
cited studies focused on different immune parameters their conclusions 
were quite convergent, showing increased activity in the adaptive im-
mune response and the presence of pro-inflammatory factors. A recent 
study on gene expression profiles of PBMCs from inhabitants of the high 
level background radioactivity area in Kerala, India found that immune 
response pathways were among the radiation-affected over-represented 
pathways (Jain and Das, 2017). 
Immune markers were investigated in people living in radiation- 
contaminated areas such as around the Mayak nuclear complex, 
including the Techa River in the Russian Federation. Akleyev et al. 
showed that the innate immune system, NKT cells, and neutrophils in 
particular, might be activated by chronic exposure to approx. 0.9 Gy in a 
dose and dose-rate dependent manner in residents of Techa River 
(Akleyev et al., 2019). Another study indicated a dose-dependent 
decrease in the concentration of T helper cells, reduced IFN-γ levels, 
increased NKT lymphocyte numbers as well as transforming growth 
factor beta (TGF-β), matrix metalloproteinase 9 (MMP-9), IgA and IgM 
levels in Mayak workers exposed to external gamma rays with or 
without internal alpha radiation. Authors concluded that changes 
detected in the immune parameters of the investigated individuals fav-
oured the maintenance of a chronic inflammatory status, which could 
contribute to the development of radiation-related late pathologies such 
as cardiovascular and malignant diseases (Rybkina et al., 2014). Very 
similar conclusions were reached by Kiselev et al., who reviewed 
immunological changes in radiation workers at a Siberian chemical 
complex (over 4000 workers), at the Mayak nuclear facility and at the 
Chepetsk chemical and metallurgical plant. The common characteristic 
of these facilities was the presence of a mixed-type exposure (external 
gamma rays and internal alpha radiation due to incorporated uranium). 
Importantly, the study recorded not only basic laboratory changes in 
immune parameters but also clinically relevant symptomatic immune 
dysfunctions such as infections, allergies, autoimmunity and immuno-
proliferative diseases and found an increased risk for immune deficiency 
leading to an infectious syndrome in nuclear industry workers compared 
to controls. Significantly elevated IgE levels in a certain group of 
workers in the absence of a relevant allergic anamnesis was also re-
ported, which might indicate a low dose radiation induced imbalance in 
humoral immunity (Kiselev et al., 2017). Gyuleva et al. basically 
confirmed most of these findings in Bulgarian nuclear power plant 
workers with additional details on individual lymphocyte sub-
populations and their activation status. Namely, they showed a subtle 
but significant decrease in the proportion of naïve CD4+62L+ cells, 
CD4+CD25+ activated/regulator T cells and an increase in activated 
CD8+CD28+ cytotoxic T cells, along with an increase in NKT cells in 
persons receiving doses below 200 mSv. Thus, they hypothesised a 
possible shift from a Th1 to Th2 response at doses above 200 mSv. The 
main added value of this study compared to the previous ones was that 
a) it took into account confounding factors such as smoking and alcohol 
consumption and b) it discussed the influence of aging as another con-
founding factor on immune parameters, which can overlap with certain 
changes seen following radiation. Though, they also showed that most of 
the changes in the measured parameters remained within the normal 
reference values illustrating the discrete effects of low doses (Gyuleva 
et al., 2018; Gyuleva et al., 2015a; Gyuleva et al., 2015b). Other occu-
pational data are from interventional cardiologists, radiologists and 
radiation workers. These studies generally report exposure doses well 
below those found in nuclear industry workers mentioned above. At 
doses of 8.14 ± 7.81 mSv/year for at least 5 years, i.e. below 50 mSv in 
cumulative dose, drastic fluctuations in circulating immune cells are 
unlikely to occur, however more subtle changes such as priming the 
immune system towards stronger Th1 response upon a secondary chal-
lenge were reported (Ahmad et al., 2016; Karimi et al., 2017; Zakeri 
et al., 2010). Occasional quantitative changes in the cellular and hu-
moral immune system components have been reported even at standard 
annual dose levels below 3.5 mSv/year with smoking being an impor-
tant confounder (Godekmerdan et al., 2004; Klucinski et al., 2014; Rees 
et al., 2004). High variability amongst “normal” individuals is an 
important limitation, especially as pre-exposure levels are rarely if ever 
known in immune epidemiological studies. Diurnal rhythm has a pro-
nounced effect that is impossible to control and individual variation in 
lymphocyte radiosensitivity is also large. 
2.3. Studies on radiation-exposed children 
There is a limited number of studies investigating immune changes in 
children exposed to chronic low dose exposures. In general, as reviewed 
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in the UNSCEAR 2013 report, children might be more at risk for a 
number of radiation-induced late effects both of stochastic and deter-
ministic nature. This is true for the incidence of certain tumors such as 
leukaemias, skin, brain and thyroid cancer as well as deterministic 
health effects such as cognitive defects, cataracts and thyroid nodules 
(Radiation, 2014). For this reason and also for the fact that the immune 
system maturation in children is still ongoing and damage at this state 
might lead to different consequences in immune function than in adults 
or older individuals with various degrees of immune senescence, we 
considered discussing studies of radiation-exposed children separately 
from those targeting adults. Chronic low dose exposure in children of 
kindergarden-age can have long-lasting effects on peripheral blood cell 
counts. Children exposed to 21–85 mSv gamma radiation over a 1–2 
year period experienced a drop in total leukocyte and neutrophil counts 
and an increase in eosinophils that lasted as long as 5–7 years after the 
end of exposure, with total lymphocyte numbers not affected when 
compared to children exposed to 2–5 mSv (Chang et al., 1999). Alter-
ations in T cell immunity were detected in children 6–13 year old living 
within a 40–75 km radius of radiation-contaminated areas around 
Chernobyl in North Ukraine and exposed to persistent low level radia-
tion. These children had lower CD4 + T cell counts and a shift in the 
immune balance towards cytotoxic T cell and NK cell subsets especially 
in vulnerable populations such as those who developed recurrent res-
piratory problems (Vykhovanets et al., 2000). The effects were more 
pronounced at doses above 1 mSv but were also seen below that dose 
(Chernyshov et al., 1997), although confounding factors such as general 
health status, individual immunogenetic make-up and exposure to 
pathogens make radiation dose response patterns difficult to ascertain. 
Though in children with irritable bowel disease living in the Chernobyl 
contaminated area no association with radiation was found (Sheikh 
Sajjadieh et al., 2012). 
The link between childhood radiation exposure and thyroid cancer 
was firmly established in the aftermath of the Chernobyl accident in 
1986 (Pacini et al., 1997), with non-cancer thyroid diseases including 
autoimmune thyroid disorders emerging a few years after the accident. 
This was less of a research focus in the A-bomb survivor cohorts, 
although thyroid pathologies were studied in middle aged adults from 
the Hiroshima and Nagasaki cohorts who were exposed in utero, with a 
mean maternal uterine dose of 0.256 Gy (range 0.005 Gy to 1 Gy). It was 
determined that they had similar risk estimates as those in the Chernobyl 
study but there was no significant linear dose response for thyroid 
nodules or autoimmune thyroid disease (Imaizumi et al., 2008). Simi-
larly, thyroid nodules tended to be much more prevalent in the 
radiation-exposed Marshallese population, but without correlating to 
abnormal thyroid function (Takahashi et al., 1999). A comprehensive 
review on the initial epidemiological studies is provided by Saenko 
et al., who concluded that the frequencies of abnormal haematological 
parameters and thyroid autoimmunity did not correlate with dose 
(Saenko et al., 2011). According to long-term studies, the rise in auto-
antibodies is very common even at lower doses but it can be transient 
and does not necessarily yield clinical thyroid autoimmune disease or 
thyroid dysfunction although well-designed long-term investigations are 
still needed (Agate et al., 2008; Eheman et al., 2003; Kasatkina et al., 
1997; Ron and Brenner, 2010). The disconnection between the rise in 
autoantibodies and the lack of clinical disease might be due to a radia-
tion damage-driven release of thyroid antigen without subsequent 
lymphocytic infiltration. One explanation is the possibility of a transient 
autoimmune reaction (Agate et al., 2008). It is also important to 
consider the dietary iodine uptake. However, determining the associa-
tion between low dose exposures and their clinical significance in terms 
of benign thyroid diseases is not without challenges, which include 
limited sample size, inadequate dose estimates, prevalence in healthy 
subsets, gender differences and technical problems that relate to the 
variety of antibodies that can be studied (Eheman et al., 2003). 
Overall, epidemiological studies on long-term low dose irradiation 
effects on the immune system indicate a) a consensus regarding 
persistent alterations in CD4+ T cell numbers and function; b) a shift 
towards humoral immunity; c) contradictory conclusions on cytotoxic 
CD8+ T cell numbers and innate immunity, most probably with a shift 
towards activation of certain NK cell compartments; d) limited knowl-
edge on changes in granulocytes; e) likely accelerated immune aging 
(Table 3). Overall, there are big gaps in our understanding of functional 
alterations in immune parameters which are of particular interest at this 
dose range. 
Results from the diverse epidemiological or human biomonitoring 
studies are difficult to compare mainly due to gross heterogeneities in 
the studied cohorts in terms of age (both in terms of age at exposure and 
time elapsed from exposure), doses received, irradiation scenarios 
(acute or chronic, external, internal or mixed exposures), presence of 
confounding factors (lifestyle, comorbidities, genetic background) and 
studied endpoints. A major drawback to almost all of these studies is 
their purely descriptive nature without much effort to link these to 
specific pathological conditions or diseases. Studies investigating im-
mune alterations in A-bomb survivors suggested a correlation between 
radiation-induced chronic inflammation and increased incidence of 
chronic degenerative-type conditions (e.g. cardiovascular diseases, 
metabolic alterations). The few observations pointing to an increase in 
the incidence or susceptibility to infections or towards an increased 
predisposition for autoimmune disorders await confirmation by further 
studies. So far, it has been difficult to discriminate between immune 
alterations that are within the normal resilience capacity of an indi-
vidual versus those that fall outside that range and might link directly to 
certain diseases. The fact that immune system alterations are part of 
many if not all pathophysiological processes leading to chronic diseases 
not traditionally considered as bona fide immune diseases (e.g. heart 
conditions) only adds further to the complexity of the issue. A meta- 
analysis of all epidemiological and biomonitoring studies would be 
useful to evaluate relevant correlations between radiation effects, im-
mune system changes and related health consequences. A better char-
acterisation of the control group and the study design (including the 
statistical analysis used), categorisation of the measured endpoints and 
reported health outcomes would help identifying the most informative 
studies. 
3. Experimental and pre-clinical data on low dose ionizing 
radiation effects on the immune system 
The number of in vitro and in vivo data about low dose IR effects on 
the immune system is increasing in parallel with a progressively 
increasing concern of the medical and scientific community regarding 
long-term biological effects of low doses. These experimental evidences 
often confirm epidemiological observations and shed light on the 
mechanisms how IR interacts with the immune system. In the following 
paragraphs, we will review the most pertinent experimental findings 
which complement epidemiological data, focusing on the link between 
basic molecular mechanisms targeted by IR and the immune system, as 
well as direct low dose effects on quantitative and functional changes in 
Table 3 
Summary of described immune effects by radiation exposure.  
Radiation effect Possible immune marker 
Imbalance of peripheral blood 
mononuclear cells 
Changes in B cell count 
Changes in T cell count 
Changes in T cell subpopulations 
Changes in NKT count 
Acceleration of immunoaging Reduction of naive T cells 
Expansion of memory T cells 
Thymus involution 
Reduction of telomere length of leukocytes 
Humoral immune response Changes in immunoglobulin level (IgA, 
IgM, IgG, IgE) 
Inflammation Pro-inflammatory response by cytokines  
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the different immune compartments. Finally, we will present regulation 
of the inflammatory response as an example of the differential mecha-
nisms and outputs initiated by low-dose versus high-dose irradiation. 
3.1. Association between DNA damage response and immune response at 
low doses of radiation 
DNA damage is considered a primary consequence of IR and the 
activation of the DDR pathway is a key factor in determining long-term 
cell fate after irradiation. IR at low doses already may induce a variety of 
lesions like double-strand beaks (DSBs) accompanied by single-strand 
breaks (SSBs) and/or oxidized bases in a bistranded or unistranded 
form. Manning et al showed increased frequency of micronucleated 
erythrocytes in the blood of mice treated in vivo with either external low 
dose X rays or with PET scan associated internal exposure with the 
radioisotope 18F-FDG (Manning et al., 2014). Rothkamm et al reported 
that quantification of γH2AX foci in the leukocytes of patients subjected 
to CT scans could reliably estimate the level of radiation exposure 
(Rothkamm et al., 2007). DNA damage after such low doses is not suf-
ficiently severe to induce cells death but can initiate danger signalling 
(Mavragani et al., 2016; Mavragani et al., 2017). Interestingly, both in 
vitro and in vivo studies have shown a remarkable persistence of the DSBs 
(as evidenced by the slow resolution kinetics of γH2AX foci) even after 
doses in the range of computed tomography (CT) scans, well below 100 
mGy. These changes were first detected and extensively studied in fi-
broblasts (Grudzenski et al., 2010; Lobrich et al., 2005; Rothkamm and 
Lobrich, 2003) but actually more recent investigations showed a similar 
persistence and delayed repair kinetics of DNA damage in lymphocytes 
as well (Beels et al., 2010; Lassmann et al., 2010). Plenty of evidence 
suggests a strong crosstalk between DDR activation and inflammatory 
response triggering primarily innate immune responses (Ermolaeva and 
Schumacher, 2013; Pateras et al., 2015) also in case of deficient DNA 
repair or persistent DNA damage (Karakasilioti et al., 2013). Damaged 
cells can release a variety of stress or danger signals called damage 
associated molecular patterns (DAMPs) which act as mediators of innate 
immune responses (Heil and Land, 2014). These endogenous molecules 
released from damaged, stressed or dying cells, in analogy to the 
pathogen-associated molecular patterns - are recognised by the pattern 
recognition receptors located within and on innate immune system cells 
and instigate inflammatory responses. DAMPs can be different cyto-
kines, DNA, RNA, ATP, intra-cellular proteins or protein fragments, etc. 
It is remarkable, that this feature of stress response is common with 
variations across organisms of different complexity and evolutionary 
phylogeny i.e. from plants to mammals (Land, 2015; Pavlopoulou et al., 
2019). 
3.2. Systemic and abscopal effects of local radiotherapy 
Although typical fraction doses for RT are 2 Gy to the tumor, 
neighboring tissues can receive a wide range of low to medium doses up 
to 0.5 Gy (Pouget et al., 2018). In many cases of RT, biological and 
clinical systemic immune and inflammatory responses were found to be 
similar to responses of the irradiated tissues reflected in changes of key 
modulators of the immune system like cytokines or chemokines. For 
example, in a study by Mathias et al differential anti- and pro- 
inflammatory responses were detected in the heart after local heart 
irradiation with low and high doses and these differential responses 
were partly reflected at systemic level, in the plasma as well (Mathias 
et al., 2015). Several studies in human patients undergoing RT support a 
time- and treatment-dependent modulation of specific cytokines at 
systemic level, which in some cases can persist up to several years post- 
treatment, indicating a definite systemic response to radiation mediated 
by inflammatory pathways (Marconi et al., 2019). These systemic phe-
nomena have also been observed in animals as reviewed in (Mavragani 
et al., 2017). Of course, these excessive immune responses not only 
contribute to chronic inflammation and tissue damage but also to 
clearance of damaged cells and tissue remodeling/regeneration (Ermo-
laeva and Schumacher, 2014). 
Thus, local RT can cause changes in tissues and organs outside the 
field of irradiation. This is called the abscopal effect (Siva et al., 2015) 
where it can cause damage to unirradiated normal tissues, or to a 
distant, non-irradiated tumor. Clinically, such effects are well recog-
nised, as patients often suffer from fatigue, diarrhea and weight loss 
during local RT. Reports of spontaneous anti-tumour abscopal responses 
are rare, since an immune tolerant state has already been established in 
the patient; Abuodeh et al reported 35 cases over 45 years, out of mil-
lions of RT patients treated during this period (Abuodeh et al., 2016). 
Since the first report by Demaria et al that the immune system was an 
integral component of the abscopal response (Demaria et al., 2004), 
there have been studies reported, in which activation of the immune 
system, commonly using checkpoint inhibitors against cytotoxic T 
lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD- 
1) and OX40 in combination with local RT, was able to induce growth 
suppression in the second unirradiated primary tumor (Esposito et al., 
2015). On the other hand, under optimal conditions (eg targeting a 
hypoxic core of the tumour with ablative RT), the anti-tumor effect can 
be achieved with RT alone (Tubin et al., 2019). Exposure of blood and 
normal tissues surrounding the tumor, including the bone marrow and 
thymus, to low-dose scatter radiation, may play a role in the abscopal 
effects affecting normal non-irradiated tissues. After both external 
beam- and radionuclide RT, persistent and statistically significant 
increased DNA damage was observed in circulating PBMCs, and their 
repair capacity was affected (Denoyer et al., 2015; Yin et al., 2019). This 
could be explained by protracted induction of DNA damage by abscopal 
effects in susceptible progenitor cells that is revealed later as increased 
unrepaired damage in PMBCs. 
3.3. Low dose radiation induced quantitative and functional changes in 
immune parameters 
Lymphocytes are very sensitive to high dose irradiation. Though, a 
more in-depth analysis reveals significant differences in the radiosensi-
tivity of the different immune cell subsets even after high doses with B 
and CD8+ T lymphocytes being more radiosensitive while dendritic 
cells (DCs), monocytes, macrophages and regulatory T cells being more 
radioresistant (Heylmann et al., 2014). Radiosensitivity of NK cells is 
controversial, with some studies reporting that NK cells are more radi-
oresistant than CD3+ cells (Bogdandi et al., 2010; Swanson et al., 2020), 
while others reporting the opposite (Falcke et al., 2018). 
Low dose radiation elicits a more heterogeneous immune response to 
radiation. Using murine models, it was shown that single low doses (up 
to 100 mGy) induced mild and transient (up to 21 days post irradiation) 
decrease in the pool of all the above mentioned splenic subpopulations 
(Bogdandi et al., 2010; Gridley et al., 2009). If similar doses were 
delivered chronically over a period of 1–17 weeks, no changes were 
detected in the short-term (Shin et al., 2010) but a long-lasting increase 
in T and B cell numbers were registered in mice after antigen stimulation 
(Ina and Sakai, 2005). Much lower doses (100 mGy/year) on the other 
hand did not impact on T or B cell pools, indicating these doses were too 
low to induce immune effects (Courtade et al., 2001). TCR repertoire 
profiling in mice showed that acute low/intermediate exposure could 
promote premature immune aging called immunosenescence. Exposure 
to a single dose of radiation was found to accelerate ageing of the pe-
ripheral TCR repertoire. The consequences of exposure were already 
visible after 1 month and lasted for 6 months. Interestingly, they were 
more pronounced in animals exposed to 0.1 Gy than in those exposed to 
1 Gy, where they were partially corrected with time, indicating that they 
can be reversed/attenuated. Of note, some of these effects were due to 
radiation-induced impairment of hematopoietic stem cells (Candeias 
et al., 2017). 
Chronic low dose rate irradiation of mice induced a) stimulation of 
innate immunity by enhancing the cytotoxicity of pre-stimulated NK 
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cells (Sonn et al., 2012; Yang et al., 2014), b) myeloid cell differentiation 
and activation, c) suppression of pro-inflammatory responses (Shin 
et al., 2010) and d) a shift towards a Th2-type T cell phenotype (Shin 
et al., 2010) due in part to radiation-induced gene expression alterations 
in CD4+ T cells (Cho et al., 2018). Low dose effects on DCs are less well 
characterized. Persa et al. showed that low and high dose acute irradi-
ation induced qualitatively different functional changes in murine 
splenic DCs in vivo. By this, low doses stimulated antigen uptake and 
lowered antigen presentation while high doses did not influence these 
parameters, on the other hand high doses increased the expression of T 
cell costimulatory markers and enhanced the production of pro- 
inflammatory cytokines (Persa et al., 2018). Other groups performing 
in vitro irradiation with doses ranging from 0.05 to 5 Gy of DC-precursors 
or mature DCs stimulated by lipopolysaccharide (LPS) reported no in-
fluence of irradiation on surface marker (CD80, CD83, CD86), cytokine 
expression or the capacity of the DCs to stimulate T-cell proliferation 
(Jahns et al., 2011). Moreover, a co-incubation of bone marrow-derived 
DCs with supernatant of LPS stimulated and irradiated macrophages 
resulted in a diminished CD40 expression but did not impact on the DC- 
derived induction of T-cell proliferation (Wunderlich et al., 2019). 
Toll-like receptors (TLR), appearing on innate immune cells induced 
DC maturation which primed T-cells. In the presence of costimulatory 
elements, cytokine release was established which lead to macrophage 
activation (Ratikan et al., 2015). Low dose fractionated irradiation of 
mice lead to increased phagocytic activity of macrophages and increased 
CD8+ T cell cytotoxicity (Pandey et al., 2005). Another pathway 
important in radiation response from the immune system is through 
nucleotide binding oligomerisation domain (NOD)-like receptors. These 
are inflammasomes, which are important in case of damage from IR or 
from viruses. The redox status of cells may work as a rheostat, which 
may lead to a vicious circle of harm in case of excess oxidation, or may 
calm down the inflammation in reduced conditions. TLR agonists like 
LPS (especially for TLR4), may influence the response to ionizing radi-
ation (Ratikan et al., 2015). 
As previously mentioned, RT can induce long lasting systemic 
changes in immune/inflammatory parameters (Marconi et al., 2019). 
These changes may appear gradually during the course of the treatment 
(Manning et al., 2017), and even further evolve in the weeks following 
its completion (Balazs et al., 2019; Frey et al., 2020). Hence, the mod-
ulation of the expression of some inflammatory (ARG1, BCL2L1, MYC) 
genes in blood cells was not apparent after the first two fractions but 
became significant after the 25th in patients treated for endometrial 
cancer. Of note, RT did not modulate these same genes as strongly in 
head and neck patients (Manning et al., 2017). This difference may be 
due to different volumes of blood being exposed at each fraction in 
endometrial and head and neck patients, or to different effects of the 
different tumour entities on the immune system. The presence of a 
carcinoma in the head and neck area have indeed been shown to pro-
mote an immunosuppressive state in patients, which is even accentuated 
(increase in Tregs, increased expression of checkpoint molecules on 
CD4+ T cells), during and after RT (Balazs et al., 2019). Systemic 
modulation of cellular and humoral immune parameters can also 
depend on the mode of radiation delivery (Frey et al., 2020). However, 
most of these studies addressed changes occurring after repeated local-
ized exposure, and it is therefore difficult to assess the exact role of low 
dose in these observations. Radiation-induced gene expression changes 
were also investigated in peripheral blood cells of RT-treated prostate 
cancer patients (El-Saghire et al., 2014) 18–24 hours after the first 
fraction (2.09 Gy), resulting in an equivalent total body blood dose of 
around 31 mGy. Gene set enrichment analysis showed the activation of 
several pathways involved in immune signaling: IFN secretion, CD28 
stimulation, antigen processing and presentation, B-cell receptor (BCR) 
and TCR activation, inflammasomes, transcription factor nuclear factor 
kappa B (NF-κB), TLR and cytokine signalling indicating that local high 
dose resulted in systemic activation of pathways involved in immune 
processes. Interestingly, the comparison of the response elicited in 
whole human blood exposed in vitro to 0.05 or 1 Gy suggested that low 
dose radiation rather induced pro-survival/anti-apoptotic and immune 
response pathways, whereas high dose exposure rather induced p53- 
dependent signaling pathways (El-Saghire et al., 2013b). A similar di-
chotomy was found for the response to low and high dose radiation of 
purified human monocytes exposed in vitro (El-Saghire et al., 2013a). 
Low, but not high dose exposure induced the transcription of genes 
involved in TLR signaling, with a concomitant activation of NF-κB, p38, 
extracellular-signal-regulated kinase (ERK) and c-Jun N-terminal kinase 
(JNK). In contrast, exposure to 1 Gy induced phosphorylation of p53 and 
transcription of p53-dependent genes (El-Saghire et al., 2013b). In vitro 
exposure of human PBMCs obtained from healthy donors to 0.05 Gy of X 
rays or 12C ions did not induce significant changes in the proportion of T 
or NK cells 24 h later. Both types of radiation induced the transcription 
and the secretion of IL-2, IFN-γ and TNF-α, and an increase in the 
cytotoxic activity of the irradiated PBMCs. These effects appeared 
stronger with high than with low LET radiation (Chen et al., 2010). 
Altogether, experimental data do not indicate a linear dose response 
relationship of immunological parameters modulation. IR may have 
qualitatively different effects at different doses/dose ranges. However, 
some responses/endpoints display discontinuous characteristics shared 
with non (DNA)-targeted properties of IR (Mothersill and Seymour, 
2011). The molecular mechanisms responsible for these non-linear dose 
response relationships, however, remain elusive and may be associated 
with a connexion of multiple pathways initiated at different threshold 
doses and following different kinetics (Mothersill and Seymour, 2011; 
Rodel et al., 2012). There is growing evidence for a mechanistic link 
between transcription factor activity including p53 protein, activating 
protein 1 (AP-1), and NF-κB in the regulation of the DDR and that of 
immune response (Habraken and Piette, 2006; Magne et al., 2006; 
Prasad et al., 1995). For example, a dose-dependent biphasic tran-
scriptional activity of NF-κB has been shown in endothelial cells (ECs) 
and macrophages (Rodel et al., 2004; Wunderlich et al., 2015). 
3.4. Initiation of anti-inflammatory vs pro-inflammatory processes by IR 
Functional changes in immune parameters after low dose exposure 
show a significant degree of heterogeneity and are often qualitatively 
different from changes induced by high doses. Inflammatory response is 
the best studied immune mechanism which is regulated differentially by 
low/medium dose and high dose irradiation. In the next paragraphs we 
summarize the current knowledge on the regulation of inflammatory 
processes by low versus high dose irradiation (Fig. 2). 
3.4.1. Modulation of basic inflammatory mechanisms by low/medium dose 
radiation exposure 
Inflammation is a basic immunological effector process in response 
to harmful stimuli, such as pathogens, damaged cells or irritants (Mur-
phy and Weaver, 2017) and is regulated by complex interactions be-
tween a variety of immune components and soluble mediators. 
Among the initial step in the inflammatory pathways is the recruit-
ment of leukocytes to the site of damaged tissue mediated by local 
adhesion to the endothelium. By analysing PBMC and poly-
morphonuclear (PMN: granulocytes) cell attachment to cytokine TNF-α 
activated endothelium a significant reduction of adhesion in the dose 
range of 0.3–0.7 Gy was among the first mechanisms reported to 
contribute to an anti-inflammatory effects of intermediate dose exposure 
(Hildebrandt et al., 2002; Kern et al., 2000; Roedel et al., 2002). These 
findings functionally coincide with secretion of the anti-inflammatory 
cytokine TGF-β1 from ECs, both in vitro and in a murine model 
(Arenas et al., 2006; Roedel et al., 2002). Subsequent studies further 
indicate an impaired adhesion to be associated with a non-linear pro-
duction of reactive oxygen species (ROS) in ECs, which is functionally 
based on a modulation of the transcription factor nuclear factor E2- 
related factor 2 (Nrf2) and anti-oxidative enzymes such as superoxide 
dismutase, catalase and glutathione peroxidase (Large et al., 2015). 
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Further, clearance of apoptotic cells by macrophages is reported to result 
in non– or even anti-inflammatory responses (Gaipl et al., 2005; Voll 
et al., 1997). In line with that, a discontinuous appearance of apoptosis 
was observed in PBMCs following 0.1–0.3 Gy irradiation (Kern et al., 
1999), which may foster a reduced adhesion. This is enhanced by a 
diminished surface expression of the adhesion molecule E-selectin on 
ECs (Hildebrandt et al., 2002; Roedel et al., 2002) or by the proteolytic 
cleavage of L-selectin from apoptotic PBMCs (Kern et al., 1999). 
A key mechanism in the subsequent effector phase of inflammation 
covers the accumulation of monocytes and their differentiation into DCs 
and inflammatory macrophages (Valledor et al., 2010). The latter sup-
port the local inflammatory process by a variety of functions such as 
phagocytosis, presentation of antigens, cytotoxic activity and secretion 
of cytokines, ROS and nitric oxide (NO) (Fujiwara and Kobayashi, 
2005). NO in turn impacts on vascular permeability, promotes tissue 
oedema and is involved in the development of inflammatory pain 
(Holthusen, 1997). Notably, irradiation at 0.3–1.25 Gy of activated 
macrophages resulted in decreased expression of the enzyme inducible 
nitric oxide synthase (iNOS) and NO production (Hildebrandt et al., 
1998) in line with a hampered release of ROS and superoxide production 
(Schaue et al., 2002) that have mechanistically been linked to the anti- 
inflammatory and analgesic effects of low-dose exposure. In addition, 
irradiation with doses up to 2 Gy significantly decreased major histo-
compatibility (MHC) II expression and transmigration of macrophages 
(Wunderlich et al., 2019) but fostered chemotaxis of LPS activated 
macrophages without impacting viability and phagocytic functions 
(Wunderlich et al., 2015). 
In order to establish experimental conditions mimicking as close as 
possible the patients situation, a human TNF-α transgenic mouse model 
was adopted to investigate the therapeutic and cellular effects of low 
dose irradiation. These animals overexpress the cytokine during their 
lifetime and develop a polyarthritis with joint swelling and deformation, 
synovial inflammation, cartilage damage, and bone erosion comparable 
to the human situation (Keffer et al., 1991). Irradiation of these mice 
with five times 0.5 Gy at early stages (4–6 weeks) revealed significantly 
reduced paw swelling and increased grip strength (Frey et al., 2009). 
More recent findings further indicate a significant reduction of inflam-
matory and erosive areas with a lowered detection of bone-resorbing 
osteoclasts and neutrophils. In addition, starting at a dose of 0.5 Gy, 
proliferation and expression of receptor activator of NF-kB ligand 
(RANK-L) in fibroblast-like synoviocytes decreased, numbers of differ-
entiated osteoclasts and their bone resorbing activity also diminished in 
line with a discontinuous dose response relationship in osteoblast- 
induced mineralization (Deloch et al., 2018a). By contrast, irradiation 
with a single dose of 0.5 Gy displayed no harmful effects on cells in 
healthy joints (Deloch et al., 2018b). Thus, one can conclude that in this 
dose range irradiation may also act via osteo-immunological mechanism 
with the anti-inflammatory properties depending on the initial inflam-
matory status (Candeias and Testard, 2015; Frey et al., 2017). In 
conclusion, recent experimental in vitro data have characterized mech-
anisms and factors that may contribute to the anti-inflammatory effect 
of a low to medium dose exposure while in vivo models have confirmed 
improvements in a variety of clinical symptoms and parameters. 
First clinical studies of patients that had been exposed to very low 
doses of high linear energy transfer (LET) radon gas (0.3 mSv) gave first 
hints that even here systemic immune modulations took place. Espe-
cially, activation status of immune cells was influenced as well as levels 
of TGF-β (Cucu et al., 2017; Kullmann et al., 2019; Ruhle et al., 2017). 
One of the most compelling observations in this patient population was a 
long-term shift within the CD4+ T cell compartment towards a higher 
proportion of circulating Tregs along with a fall in CD8+ T cells after 
cumulative doses of around 0.3 mSv (Cucu et al., 2017). Decreased 
levels of lymphocytes expressing the activation marker CD69 and a 
temporary rise in systemic TGF-β and higher IL-18 serum levels were 
found to directly relate to better pain control in patients after radon spa 
treatment (Kullmann et al., 2019). 
3.4.2. Lung injury during radiotherapy – A clinical example of radiation- 
induced pro-inflammatory pathology 
The lung is one of the most radiosensitive organs, and RT-associated 
Fig. 2. Schematic representation of the most important immune- and inflammation-related processes developing after low, intermediate and high dose irradiation 
based on available epidemiological, clinical and experimental data. 
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lung tissue inflammation can occur early (radiation pneumonitis, within 
6 months) and late (chronic lung fibrosis, later than 6 months) after RT 
(Giridhar et al., 2015). Currently, radiation pneumonitis develops in 
about 30% of patients and is fatal in 2% (Palma et al., 2013). It is the 
main dose-limiting toxicity and can limit quality of life of cancer sur-
vivors. Genetic factors contribute to the severity of the radiation- 
induced pneumonitis and fibrosis (Gatti, 2001). Pathophysiology, mo-
lecular and cellular mechanisms of these injuries have been described 
(Giridhar et al., 2015; Huang et al., 2017), however still remain not fully 
understood. 
After irradiation, as a consequence of radiation-induced oxidative 
stress the DDR is dysregulated in lung, resulting in a population of cells 
with unrepaired DNA damage. This in turn leads to destruction of 
alveolar epithelial and vascular ECs inducing tissue hypoxia. Oxidative 
stress and tissue hypoxia are important regulators of cellular signalling 
pathways controlling the production of various factors involved in the 
development of radiation-induced lung injury such as secretion of pro- 
inflammatory and pro-fibrogenic cytokines, growth factors and pro-
teases that destroy the extracellular matrix and the barrier of lung tissue. 
Hypoxia-inducible factor 1α (HIF-1α) protein is an important tran-
scription factor involved in the development of radiation-induced lung 
injury, which is expressed early after irradiation as a consequence of 
oxidative stress and tissue hypoxia and its expression progressively in-
creases for months thereafter. Once induced, it regulates the expression 
of a series of genes involved in pathways like inflammation, oxidative 
stress response, proliferation, differentiation or angiogenesis (Imtiyaz 
and Simon, 2010; Jackson et al., 2012; Rabbani et al., 2010). Blood 
vessel dilation and increased permeability allows for accumulation of 
inflammatory cells (with macrophages being the most prominent cell 
types) at the site of irradiated tissue and in the alveolar cavity and cause 
a strong immune response. This acute inflammatory response may lead 
to radiation pneumonitis that induces a vicious circle of further 
inflammation and finally fibrosis induction. IR leads to release of cyto-
kines as well. A first wave of cytokine release settles within two weeks. 
The second wave starts around 6–8 weeks post-irradiation (Rube et al., 
2004) and is associated with accumulation of oxidative DNA damage, 
ROS or reactive nitrogen species (RNS), hypoxia, TGF-β expression, and 
decreased lung perfusion. TGF-β, in particular, TGF-β1, is mainly 
generated by activated macrophages and is a key player in development 
of fibrosis. It triggers proliferation and conversion of fibroblasts to 
myofibroblasts. Myofibroblasts in turn produce excessive collagen and 
other extracellular matrix components, and secrete angiotensin and 
hydrogen peroxide, which induce apoptosis in alveolar epithelial cells. 
Activin A is induced by TGF-β1 and it also stimulates production of 
collagen (Forrester et al., 2017). Fibrosis induces hypoxia and conse-
quent release of pro-fibrotic and pro-angiogenic factors like TGF-β1 
(Vujaskovic et al., 2001). These cycles are the basis of RT-induced 
chronic inflammatory lung disease. 
Clinical predictors have been identified in an effort to minimize ra-
diation pneumonitis. Since the inflammatory response underlies RT- 
related lung toxicities, immunological factors involved in this response 
may provide potential biomarkers to predict individual response to RT. 
Lierova et al. recently reviewed 56 articles that have evaluated the as-
sociation between serum cytokines and pneumonitis in irradiated lung 
cancer patients, most of them receiving around 60 Gy (Lierova et al., 
2018). Serum IL-6 and TGF-β1 tended to stand out in predicting sus-
ceptibility to subacute pneumonitis, whereas circulating IL-4 and IL-13 
appeared more critical for delayed effects such as chronic inflamma-
tion and fibrosis. Higher grade pulmonary toxicity in lung cancer pa-
tients was associated with early changes during RT treatment in plasma 
levels of IP-10, MCP-1, eotaxin, IL-6, and tissue inhibitor of matrix 
metalloproteinase 1 (TIMP1) (Siva et al., 2016; Siva et al., 2014). The 
expression levels of follistatin, the member of TGF-β superfamily, 
fibrillin-2, which stores the latent form of TGF-β in extracellular matrix 
and inhibits its activation, and dermatopontin, which increases cellular 
response to TGF-β, predicted lung radiosensitivity manifested as 
radiation-induced fibrosis (Forrester et al., 2014). Vascular endothelial 
growth factor, E-selectin, I-selectin, basic fibroblast growth factor 
(bFGF), IL-1, IL-6, IL-8, IL-10, IL-12 and IL-18 have also been suggested 
as possible predictive biomarkers (Sprung et al., 2015). 
Chronic inflammatory responses as predictors of radiation toxicity 
have also been described in patients treated with RT for other malig-
nancies than lung cancer. A recent review by Marconi et al. included 15 
publications from the last 5 years on breast cancer patients receiving RT, 
many with conventionally fractionated regimens to a total dose of 50 Gy. 
Some radiation-driven changes in cytokine levels persisted in these pa-
tients for months, such as IFN-γ and TGF-β. Similarly to lung, both IL-6 
and TGF-β correlated with radiation toxicity, although tumour stage and 
timing were important factors, too (Marconi et al., 2019). Moreover, in 
37 patients with prostate cancer receiving RT, cytokines were reported 
to appear in recurring waves with pro-inflammatory IL-1 and macro-
phage colony-stimulating factor (M-CSF) preceding TGF-β1 but more 
importantly the magnitude of these waves correlated with doses up to 9 
Gy given in daily 1.8 Gy fractions (Kovacs et al., 2003). 
Altogether, these clinical observations indicate that chronic inflam-
matory reactions are key players in the pathophysiology of high dose 
irradiation-induced normal tissue toxicity. 
Although not directly linked to the topic of the paper, we would like 
to briefly mention that a cancer developing in an inflammatory micro-
environment is in general more radioresistant compared to a cancer 
where chronic inflammation is not present. The link between local 
inflammation and cancer radioresistance is thoroughly investigated and 
several excellent reviews exist on this topic (Aggarwal et al., 2009; 
Jarosz-Biej et al., 2019; Multhoff and Radons, 2012; Woodward et al., 
2010). 
An important point to consider when comparing inflammatory re-
sponses after cancer RT with low dose radiation treatment of benign 
diseases is the different initial temporal and spatial states of the immune 
system. Many cancer patients have a more immune-suppressive tumor 
microenvironment, in contrast to the chronic inflammatory state in 
benign disease; both of which are far from the more balanced, neutral 
set-point in healthy people. As the baseline immune balance has shifted, 
the effect of radiation will shift also. 
3.5. The role of genetic background in the variability of radiation effects 
on the immune system 
Individual variation in response to IR is well documented in cancer 
patients receiving RT and radiosensitive patients can present therapy- 
related side effects such as fibrosis, necrosis, dermatitis, esophagitis, 
neuropathological disorders, inflammation and vascular damage, 
among others (Pavlopoulou et al., 2017). The mechanism of inflam-
mation and fibrosis developing in lung after RT has been described in the 
previous chapter and it is evident that many of the adverse effects 
involve processes of the immune system. Heritability studies suggest 
that 58–82% of the individual variation in sensitivity to radiation and in 
the development of RT-related toxicity can be attributed to genetic 
factors (West and Barnett, 2011). Currently the role of the genetic 
background in individual radiosensitivity has almost exclusively been 
investigated for high doses and practically no data exist in the literature 
regarding low dose effects. We aim to provide a short summary of the 
data available regarding the role of the genetic background in the im-
mune system changes influencing individual radiation response. 
Several studies with murine models have shown genotype-dependent 
inflammatory-type responses after whole-body irradiation. For example, 
macrophages from CBA/Ca mice exhibited a pro-inflammatory pheno-
type, whereas those from C57BL/6 showed an anti-inflammatory 
phenotype after irradiation with 4 Gy (Coates et al., 2008; Rastogi 
et al., 2013). Moreover, different immune-related outputs were obtained 
after doses below 100 mGy in two mouse strains with different sensi-
tivity to radiation-induced mammary carcinoma: the sensitive strain but 
not the resistant one showed transcriptional signatures of macrophage 
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activation, pattern recognition receptor signalling, NK cell and TGF-β 
signalling. While changes in immune gene signatures were transient, 
activation of various cancer pathways in the sensitive strain after irra-
diation was a durable effect (Snijders et al., 2012). This would confirm 
the importance of genetic background in low dose IR-induced effects. 
It is well known that rare mutations in DNA DSB repair genes can 
cause heritable syndromes, such as ataxia telangiectasia, that show 
extreme radiosensitivity. However, radiosensitivity is now considered 
not to rely only on a single rare gene mutation but to be an inherited 
complex trait that depends on the interaction of common risk alleles in a 
large number of genes (Andreassen et al., 2002). The different responses 
to RT in patients treated with the same radiation doses and not affected 
by one of the above-mentioned heritable syndromes, support the 
consensus of the involvement of common genetic factors in radiosensi-
tivity (Guo et al., 2015). 
The degree of the association between specific genes and pathways 
and sensitivity to radiation probably depends on the specific tissue 
involved and the particular endpoint analysed (Andreassen et al., 2002). 
Focusing on the immune system, some genetic variants (mainly single 
nucleotide polymorphisms (SNPs)) have been found to be associated 
with inflammation and fibrosis after radiation and in particular after RT 
(Table 4). For example, in early studies with relatively small sample 
sizes, polymorphisms in glutathione S-transferase alpha1 (GSTA1), 
glutathione S-transferase pi1 (GSTP1), TGF-β1, thioredoxin reductase 2 
(TXNRD2), and X-ray repair cross-complementing 1 (XRCC1) genes 
were found to be significantly associated with radiation-induced fibrosis 
in breast cancer patients. On the other hand, polymorphisms in ataxia 
telangiectasia mutated (ATM), ERCC excision repair 5, endonuclease 
(ERCC5), mouse double minute 2 (MDM2), XRCC1 and XRCC3 were 
associated with fibrosis in naso-pharyngeal cancer patients. This would 
agree with the tissue-specificity of the associations in some cases. 
However, some studies failed to replicate the initial associations for 
TGF-β1, XRCC1 and XRCC3 (see Table 4 for references). 
Later, more-powered studies were carried out (and some are still 
ongoing) in collaborative projects with thousands of patients, e.g. 
RadGenomics (Iwakawa et al., 2002), GENEPI (Baumann et al., 2003), 
Gene-PARE (Ho et al., 2006), RAPPER (Burnet et al., 2013), and 
REQUITE (Seibold et al., 2019; West et al., 2014). These collaborative 
projects have successfully identified association of alleles from the MHC 
III region with fibrosis in 2036 breast cancer patients and of ribonu-
clease L (RNASEL) gene with IL-6 levels in 2550 prostate cancer patients 
(Meyer et al., 2010; Talbot et al., 2012). However, a large study with 
2782 patients reported no association of a SNP in TGF-β1 gene with RT- 
induced breast fibrosis (Barnett et al., 2012). Similarly, results from Zhu 
et al. with 2926 patients with several cancer types failed to find a cor-
relation between TGF-β1 SNPs and fibrosis after RT (Zhu et al., 2013). 
All these studies were focused on candidate genes suspected to be 
causally related to radiation toxicity, such as DNA damage recognition 
and repair, free radical scavenging or anti-inflammatory response. Be-
sides the candidate-gene approach, few genome-wide association 
studies (GWAS) have been carried out to unravel genes important in 
radiosensitivity unbiasedly (Barnett et al., 2014; Fachal et al., 2014; 
Kerns et al., 2016; Kerns et al., 2010; Kerns et al., 2013a; Kerns et al., 
2013b; Kerns et al., 2013c). Most of these GWAS provided evidence for 
associations of polymorphisms with overall toxicity after RT or with 
individual endpoints other than inflammation or fibrosis, so candidate 
gene approach studies previously mentioned (Table 3) could not be 
confirmed or refuted. However, some GWAS identified genetic variants 
that may underlie the variability of radiation effects on the immune 
system, specifically in prostate cancer patients treated with RT and who 
presented rectal bleeding, which could be caused by proctitis or 
inflammation of the rectum (Kerns et al., 2016; Kerns et al., 2013c). 
Recently, Kerns et al. performed a meta-analysis with 3871 prostate 
cancer patients and identified one SNP significantly associated with 
rectal bleeding (Kerns et al., 2020). 
In conclusion the role of genetic background in shaping the 
Table 4 
List of genes reported to be significantly associated with immune-associated 
endpoints after radiotherapy. Only studies with >100 samples were included. 
*BC, breast cancer; HNC, head and neck cancer; LC, lung cancer; PC, prostate 
cancer.  
Endpoint Tumor 
type* 
Genes 
associated 
with the 
endpoint 
Genes with 
contradictory 
results 
References 
Dermatitis BC ABCA1, 
IL12RB2  
(Isomura et al., 
2008)  
HNC GSK3B, 
MDM2, 
XRCC1  
(Borchiellini 
et al., 2017; 
Chen et al., 
2017; Yu et al., 
2016) 
Esophagitis LC BLM HSPB1, 
PRKCE, 
TGFB1, 
TNFSF7  
(Guerra et al., 
2012; Lopez 
Guerra et al., 
2011; Pu et al., 
2014; Zhao 
et al., 2016) 
Fibrosis BC ATM (lung 
fibrosis), Class 
III MHC 
region, 
GSTA1, 
GSTP1, 
TXNRD2 
TGFB1, XRCC1 (Barnett et al., 
2010; Barnett 
et al., 2012; 
Edvardsen 
et al., 2013; 
Edvardsen 
et al., 2007; 
Giotopoulos 
et al., 2007; 
Grossberg et al., 
2018; Quarmby 
et al., 2003; 
Seibold et al., 
2015; Talbot 
et al., 2012; 
Terrazzino 
et al., 2012)  
HNC ATM, ERCC5, 
HDM2, 
XRCC1 
XRCC3 (Alsbeih et al., 
2014; 
Borchiellini 
et al., 2017; 
Cheuk et al., 
2014)  
Several 
cancers 
ATM  (Zhang et al., 
2016) 
IL6 levels PC RNASEL  (Meyer et al., 
2010) 
Mucositis HNC APC, ATG10, 
ATG16L2, 
EDN1, NBN 
XRCC1 (Chen et al., 
2017; Ma et al., 
2017; Pratesi 
et al., 2011; 
Venkatesh 
et al., 2014; 
Yang and Liu, 
2019; Yu et al., 
2016) 
Pneumonitis LC AKT2, 
ATG16L2, 
BMP2, 
DDX58, 
ERCC1, 
GSTP1, 
HIPK2, IL4, 
IL8, LIN28B, 
MTHFR, 
MUS81, 
NEIL1, 
NFKBIA, 
PI3CA, 
RAD51, SP-D, 
TNF, TOPBP1, 
TP53 
APEX, ATM, 
CBLB, HSPB1, 
IL1A, IL13, LIG4, 
MIF, NOS3, 
TGFB1, 
TNFRSF1B, 
VEGF, XRCC1 
(Chen et al., 
2013; Du et al., 
2018a; Du et al., 
2018b; 
Hildebrandt 
et al., 2010; Li 
et al., 2014; Li 
et al., 2016; 
Mak et al., 
2012; Niu et al., 
2012; Pang 
et al., 2013; Pu 
et al., 2014; 
Tang et al., 
2016; Tang 
et al., 2019; 
Tang et al., 
2020; Voets 
et al., 2012; 
(continued on next page) 
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individual immune response after high doses is well demonstrated even 
in the absence of identified consensus on the identity of the gene(s) or 
gene cluster(s) responsible for this effect. While studies investigating the 
role of genetic background in individual immune parameters to low dose 
IR are very scarce in the literature there is no doubt that an individual 
genetic signature is crucial in low dose response as well, especially 
taking into account the high inter-individual variability of low dose ef-
fects, which are most probably governed by genetic (and epigenetic) 
factors. This highlights the future need to focused research deciphering 
the role of genetic background in low dose regulated immune responses. 
4. Conclusions 
There is a wealth of scientific evidence based on epidemiological 
data from various cohorts exposed to different radiation doses, dose 
rates and radiation qualities as well as clinical studies and experimental 
in vitro and in vivo data, all collectively supporting the notion that low 
dose IR affects the immune system in multiple ways. 
The most important of these findings can be summarized as follows:  
1. Both studies on human subjects and experimental data indicate low 
dose radiation-induced damage on T cell immunity, especially CD4+
T cells. There is a fair amount of consensus in the literature on low 
dose radiation doses driving changes in the functional profile of 
CD4+ T cells, most often a shift towards a Th2 phenotype. CD8+
damage (both quantitative and functional) is also reported in most 
studies but there are discrepancies as to their radiosensitivity and 
their functional impairment depending on whether acute or long 
term chronic exposures were performed. It is also known that T cell 
activation can drive radioresistancy, which may explain some of 
these discrepancies.  
2. Data regarding low dose radiation effects on humoral immunity 
mostly arise from epidemiological observations and relatively few 
experimental studies have focused on this component of the immune 
system. While most studies show some degree of humoral immune 
enhancement, these are in contradiction with sporadic reports on an 
increased proneness to bacterial infections among radiation exposed 
individuals, although this may vary with the infectious agent.  
3. Within the innate immune system, NK cells are perhaps the best 
studied lineage and there is a relative consensus both in epidemio-
logical and experimental data on the role of low dose radiation in 
stimulating certain types of NK cells. Reports about low dose 
radiation effects on other components of the innate immune system 
are either contradictory (DCs) or are too few (polymorphonuclear 
cells) to allow for any pertinent conclusion regarding their behaviour 
post exposure.  
4. There is an interesting dichotomy when it comes to inflammatory 
responses in the context of low dose radiation. We can surely state 
that low-to-moderate doses of low and high LET radiation have anti- 
inflammatory effects on individuals with local inflammatory condi-
tions and may result in improvement in a variety of clinical symp-
toms and parameters. On the other hand long-term observations of 
cohorts exposed to very low doses of radiation (acute or chronic) 
indicate a pro-inflammatory immune profile, which might contribute 
to increased incidence of chronic degenerative diseases with an in-
flammatory component.  
5. Epidemiological studies were the first to raise the possibility of a 
radiation-induced acceleration of immune aging as well as radiation- 
induced metabolic perturbations in immune cells. Recently experi-
mental data seem to validate these observations, though low dose 
studies in these topics are extremely few. 
5. Recommendations for future research 
Despite all the data presented here, there are still some research gaps 
that need to be filled and we present some recommendations for future 
studies:  
1. Dysregulation of the immune system is thought to play a key role in 
many adverse health outcomes following exposure to IR. These can 
be cancerous or non-cancerous, such as cardiovascular, neuro-
cognitive and metabolic diseases, as described by Tapio et al. in 
another paper of this special issue. Clearly one of the greatest gaps in 
epidemiological studies is that immune changes identified in 
different cohorts are not linked to changes in the incidence of 
particular diseases. These are intricately linked and need to be 
studied together, i.e. the role of the immune system in radiation- 
induced chronic non-cancer diseases such as cardiovascular, neuro- 
cognitive, metabolic diseases or autoimmune disorders. A better 
understanding of the mechanisms would allow us to develop effec-
tive countermeasures and to identify predictive biomarkers. Given 
the nature of the immune system, immune parameters considered to 
be in the normal range show very high variability in the population 
at large but are relatively constant at an individual level. Hence, 
looking at population means might easily mask individual changes. 
Ideally, in order to correctly evaluate individual changes they should 
be compared to pre-exposure values of the particular individual if 
possible, in addition to mean values of control population. Since 
most immune monitoring is performed on blood samples, future 
epidemiological studies should aim to include data from pre- 
exposure blood samples as well as include potential covariates/ 
confounders such as additional stressors, lifestyle factors and genetic 
background.  
2. Most evidence indicates that the relationship between IR exposure 
and immunological changes is anything but linear. In some instances, 
low, intermediate and high IR doses of different radiation qualities 
and applied in different dose rates induce discontinuous or biphasic 
effects on the immune system. However experimental data also show 
that low/intermediate versus high doses (or dose ranges) induce 
qualitatively different shifts in immune responses (e. g. the shift from 
Th1 to Th2 profile of T helper cells or a shift from a pro-inflammatory 
towards an anti-inflammatory response or vice versa). The effects of 
low/intermediate doses may depend on the initial inflammatory 
state of the irradiated tissue, the dose rate and quality of radiation. 
Big gaps exist in our knowledge of the molecular events responsible 
for these different response patterns. A better understanding of these 
mechanisms would enable a better control of radiation-induced im-
mune changes. In line with that, one major characteristics of the 
Table 4 (continued ) 
Endpoint Tumor 
type* 
Genes 
associated 
with the 
endpoint 
Genes with 
contradictory 
results 
References 
Wang and Bi, 
2010; Wen 
et al., 2018; 
Wen et al., 
2014; Xiong 
et al., 2013; Xu 
et al., 2019; 
Yang et al., 
2017; Yang 
et al., 2011; Yin 
et al., 2011a; 
Yin et al., 
2011b; Yin 
et al., 2012a; 
Yin et al., 
2012b; Yuan 
et al., 2009; 
Zhang et al., 
2010; Zhao 
et al., 2016)  
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immune system is a high degree of cellular motility and interaction 
dynamics of the different components to activate host-protective 
activities and to terminate immune responses to counteract chronic 
and harmful activation. Thus, multiple sampling and the usage of 
multiplexed, high-resolution in situ examination is recommended to 
unravel the complexity of immune interactions.  
3. Syngenic animal studies and image guided irradiation of distinct 
locations in animals can greatly help in understanding radiation- 
induced immune changes. However, emphasis should be placed on 
long-term follow-up studies to identify persistent rather than tran-
sient immune changes. Currently available animal experiments are 
mostly investigating acute or short-term changes which are not really 
relevant for identifying late occurring pathological immune-related 
alterations.  
4. It might be useful to take into account the state of the art in other 
fields in the study of the effects of IR on the immune system. Firstly, 
the immune system has a vast but limited number of mechanisms to 
respond to stressors. Commonalities of the mechanisms induced by 
stressors not related to IR can be expected and useful to elucidate 
radiation-related mechanisms. Secondly, immune responses in other 
organisms (including invertebrates and plants) may be one of the 
synergetic fields of research between radiobiologists and radio-
ecologists. Third, as combined stressors reflect better the reality than 
exposure to IR alone, an exposome research approach considering 
the effects of environmental pollutants, nutrition, lifestyle factors as 
suggested above might be needed to reveal a more realistic effect of 
IR.  
5. Concerning the medical applications of low dose IR, there is a need to 
further explore the immunomodulatory effect of both low and high 
LET radiation. For example for radon, the development of suitable in 
vivo platforms and basic models in line with extended translational 
and clinical research is seriously needed. 
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